Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid

International Journal of Antimicrobial Agents

Volumn 24, Issue 1, 2004, Pages 83-84

  Bassetti, Matteo ^a   Di Biagio, Antonio ^a   Del Bono, Valerio ^a   Cenderello, Giovanni ^a   Bassetti, Dante ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Endocarditis; Linezolid; MRSA

Indexed keywords

ANTIHISTAMINIC AGENT; LINEZOLID; RIFAMPICIN; STEROID; TEICOPLANIN;

AGED; ANAMNESIS; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD TOXICITY; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LIVER TOXICITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT WITHDRAWAL;

ACETAMIDES; ANTI-INFECTIVE AGENTS; ENDOCARDITIS, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 3042600586     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.12.018     Document Type: Article

References (11)

1. Terpenning M.S., Buggy B.P., Kauffman C.A. Infective endocarditis: clinical features in young and elderly patients. Am. J. Med. 83:1987;626-634
2. Gagliardi J.P., Nettles R.E., McCarty D.E., Sanders L.L., Corey G.R., Sexton D.J. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin. Infect. Dis. 26:1998;1165-1168
3. Watanakunakorn C. Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991, an analysis of 106 cases. Arch. Intern. Med. 154:1994;2330-2335
4. Chien J.W., Kucia M.L., Salata R.A. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin. Infect. Dis. 30:2000;146-151
5. Birmingham M.C., Craig R.R., Hafkin B., et al. Critical care patients with significant resistant, gram-positive infections enrolled in the linezolid compassionate use protocol. Crit. Care. Med. 27:1999;S42
6. Clemett D., Markham A. Linezolid. Drugs. 59:2000;815-827
7. Melzer M., Goldsmith D., Gransden W. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremia. Clin. Infect. Dis. 31:2000;208-209
8. Patel R., Piper K.E., Rouse M.S., Steckelberg J.M. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother. 44:2000;3438-3440
9. Bassetti M., Di Biagio A., Cenderello G., et al. Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). J. Infect. 43:2001;148-151
10. Dailey C.F., Dileto-Fang C.L., Buchanan L.V., et al. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 45:2001;2304-2308
11. Chiang F.Y., Climo M. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 47:2003;3002-3004